Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

ASTELLAS PHARMA US, INC

Filed by THEGROUP DC, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 20, 2026
Income
$70,000.00
Expenses
Not reported
Filing UUID
a6f6d523-75d4-435a-977e-490f82468e71
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

H.R. 1300, PSA Screening for HIM Act Prostate-Specific Antigen Screening for High-risk Insured Men Act Issues related to the treatment of menopause and womens health at mid-life.

Literal federal measure citations: H.R. 1300

PHA · Pharmacy

H.R. 1300, PSA Screening for HIM Act Prostate-Specific Antigen Screening for High-risk Insured Men Act Issues related to the treatment of menopause and womens health at mid-life.

Literal federal measure citations: H.R. 1300

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.